Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin

Transfusion

Volumn 44, Issue 12, 2004, Pages 1720-1723

  Nester, T A ^a   Rumsey, D M ^b   Howell, C C ^b   Gilligan, D M ^b   Drachman, J G ^b   Maier, R V ^b   Kyles, D M ^b   Matthews, D C ^b   Pendergrass, T W ^b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

ADOLESCENT; ALLOIMMUNIZATION; ANTIBODY SCREENING; APLASTIC ANEMIA; ARTICLE; BLOOD GROUP O; BLOOD GROUP RHESUS SYSTEM; CASE REPORT; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HUMAN; IMMUNIZATION; LABORATORY TEST; SCHOOL CHILD; SEROLOGY;

ADOLESCENT; CHILD; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; ISOANTIBODIES; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 10444251752     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.04161.x     Document Type: Article

References (18)

1. Mollison PL. The Rh blood group system. In: Mollison PL, Engelfriet CP, Contreras M, eds. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell; 1997:169-77.
2. Thomson MICROMEDEX healthcare series. Vol. 113 Greenwood Village (CO): Thomson MICROMEDEX; 1974-2002.
3. Bowman HS, Mohn JF, Lambert RM. Prevention of maternal Rh immunization after accidental transfusion of D (Rho) - positive blood. Vox Sang 1972;22:385-96.
4. Werch J, Todd C. Resolution by erythrocytopheresis of the exposure of an Rh-negative person to Rh-positive cells: an alternative treatment. Transfusion 1993;33:530-2.
5. Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D- pediatric patients receiving D-incompatible single donor platelets. Transfusion 2002;42:177-82.
6. Cid J, Ortin X, Elies E, et al. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002;42:173-6.
7. Goldfinger D, McGinnis MH. Rh-incompatible platelet transfusions: risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971;284:942-4.
8. Lichtiger B, Surgeon J, Rhorer S. Rh-incompatible platelet transfusion therapy in cancer patients: a study in 30 cases. Vox Sang 1983;45:139-43.
9. Baldwin ML, Ness PM, Scott D, et al. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988;28:330-3.
10. McLeod BC, Piehl MR, Sassetti RJ. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients. Vox Sang 1990;59:185-9.
11. Heim MU, Bock M, Kolb HJ, et al. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sang 1992;62:165-8.
12. Zeiller TH, Wittmann G, Zingsem J, et al. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD sensitization after RhD-incompatible single donor platelet transfusion (letter). Vox Sang 1994;66:243.
13. Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000;111:980-3.
14. Isaak E, Coburn S, Grindon A. Rh-negative trauma patients are less likely to develop anti-D when transfused with Rh positive blood. Transfusion 2002;42:27S.
15. Blumberg N, Heal JM, Gettings KF. Leukoreduction of red cell transfusions is associated with a decreased incidence of red cell alloimmunization. Transfusion 2002;42:26S.
16. Anderson B, Shad A, Gootenberg J, Sandler SG. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD). Am J Hematol 1999;60:245-7.
17. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003;43:1661-6.
18. Parker C. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions. CMAJ 2000;163:881.